The Beauty Health Company (SKIN)

Market Cap	188.70M
Revenue (ttm)	301.92M
Net Income (ttm)	-11.75M
Shares Out	127.50M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	9.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	283,477
Open	1.430
Previous Close	1.450
Day's Range	1.425 - 1.495
52-Week Range	0.780 - 2.690
Beta	1.19
Analysts	Buy
Price Target	2.42 (+63.51%)
Earnings Date	Nov 6, 2025

About SKIN

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1997
• Employees: 769
• Stock Exchange: NASDAQ
• Ticker Symbol: SKIN
• Website: https://www.beautyhealth.com

Financial Performance

In 2024, The Beauty Health Company's revenue was $334.29 million, a decrease of -16.00% compared to the previous year's $397.99 million. Losses were -$29.10 million, -70.94% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for SKIN stock is "Buy." The 12-month stock price target is $2.42, which is an increase of 63.51% from the latest price.

Price Target

$2.42

(63.51% upside)

Analyst Consensus: Buy